Amodiaquine is a 4-aminoquinoline antimalarial structurally related to chloroquine, accumulating in the parasite's digestive vacuole to disrupt haem detoxification, and is commonly used in fixed-dose combination with artesunate for uncomplicated malaria. Simson Pharma's Amodiaquine reference standard and impurities support QC for this WHO-listed antimalarial combination.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amodiaquine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.